It is not without reason that the Indian pharmaceutical industry was called “pharmacy to the world”.
The voice from India was often heard on the international stage campaigning for public health. Hark back to the World Trade Organization ministerial conference at Doha (2001), where India played a role in securing a landmark declaration on public health that allowed countries to act in the interest of citizens.
The same year, Indian drugmaker Cipla offered to supply HIV/AIDS drugs at a dollar a day in Africa, another game changer on access. In fact, many Indian drugmakers have been at the forefront of supplying less expensive medicines to several countries, touching patient lives across the world.
In comparison, the response to the pandemic novel coronavirus (Covid-19) has been rather mellow, to put it mildly. Industry watchers are struck by the relative silence from the Indian pharmaceutical industry, when they should have been out there, instilling confidence on supplying the required medicines, both locally and abroad, if need be. Only Serum Institute and Zydus Cadila (working on vaccines to tackle the virus) and less-known companies like Lasa Supergenerics (working on anti-viral Favi piravir) have shown the enterprise of yore.
This story is from the March 28, 2020 edition of The Hindu Business Line.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the March 28, 2020 edition of The Hindu Business Line.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Covid Presents An Opportunity For India
India must attract investors exiting China post-Covid. Streamlining of project clearances and relaxation in FRBM norms will help
Did Alternative Assets Shield You From Covid-19 Volatility?
The assets closely linked to stock and debt markets could not stave off the losses
How To Put Aircraft To Bed
Preserving grounded planes, to get them up and flying at short notice, is a challenging task. Ashwini Phadnis captures the process
There Can Be No Going Back On WFH
Covid-19 has fast-forwarded the shift to ‘work from home’. However, some face-to-face connect will always be needed
UN, WHO Urged To Ensure ‘Benefit Sharing' Of Covid-Related Data
Biopharma firms should reach vaccines, medicines to poor nations at an affordable price, say civil society bodies
With No Clear Signal From Rlys, States Explore Ways To Bring Back Migrants
Quarantine centres, cross-country buses being arranged even as migrants hop on to boats, trucks and ambulances
Centre Allows All Neighbourhood Shops To Open But With Riders
Final call will be taken by local authorities; shopping complexes that draw fewer ‘outsiders’ are permitted to operate
Covid Impact Relatively Muted In India
Compared to Italy and the US, India’s rate of infection spread has been slow. This can be attributed to the strict measures in place
How Global Trade Will Fare Post-Covid
China isn’t likely to lose its pre-eminent position soon. India, for one, will need to make manufacturing globally competitive
How To Curb Harassment In The Virtual Office
Training and sensitisation are essential. Institute a strict dress code and chat etiquette to ensure professionalism during video calls